$HAE
HAEMONETICS CORP

2020 Q3 Form 10-Q Financial Statement

#000031314320000076 Filed on November 04, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3
Revenue $209.5M $252.6M
YoY Change -17.06% 4.55%
Cost Of Revenue $103.7M $125.6M
YoY Change -17.38% -3.17%
Gross Profit $105.7M $127.0M
YoY Change -16.74% 13.49%
Gross Profit Margin 50.48% 50.28%
Selling, General & Admin $63.57M $77.92M
YoY Change -18.42% 0.87%
% of Gross Profit 60.12% 61.36%
Research & Development $6.763M $7.422M
YoY Change -8.88% -13.53%
% of Gross Profit 6.4% 5.84%
Depreciation & Amortization $20.90M $27.10M
YoY Change -22.88% 7.11%
% of Gross Profit 19.76% 21.34%
Operating Expenses $46.96M $77.26M
YoY Change -39.22% -9.98%
Operating Profit $58.78M $49.74M
YoY Change 18.18% 90.75%
Interest Expense -$3.800M -$4.700M
YoY Change -19.15% 56.67%
% of Operating Profit -6.46% -9.45%
Other Income/Expense, Net -$3.826M -$4.651M
YoY Change -17.74% 53.04%
Pretax Income $54.96M $45.09M
YoY Change 21.89% 95.72%
Income Tax $6.900M $7.600M
% Of Pretax Income 12.56% 16.86%
Net Earnings $48.10M $37.49M
YoY Change 28.32% 100.18%
Net Earnings / Revenue 22.96% 14.84%
Basic Earnings Per Share $0.95 $0.74
Diluted Earnings Per Share $0.94 $0.72
COMMON SHARES
Basic Shares Outstanding 50.70M shares 50.79M shares
Diluted Shares Outstanding 51.09M shares 52.05M shares

Balance Sheet

Concept 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $279.2M $112.0M
YoY Change 149.29% -43.94%
Cash & Equivalents $279.2M $112.0M
Short-Term Investments
Other Short-Term Assets $34.40M $34.70M
YoY Change -0.86% 24.82%
Inventory $305.2M $244.5M
Prepaid Expenses
Receivables $141.5M $176.5M
Other Receivables $0.00 $0.00
Total Short-Term Assets $760.3M $567.8M
YoY Change 33.9% 2.71%
LONG-TERM ASSETS
Property, Plant & Equipment $240.4M $264.2M
YoY Change -9.02% -23.31%
Goodwill $214.6M $211.0M
YoY Change 1.68% 0.09%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $71.38M $29.61M
YoY Change 141.11% 141.59%
Total Long-Term Assets $657.9M $622.8M
YoY Change 5.64% -12.65%
TOTAL ASSETS
Total Short-Term Assets $760.3M $567.8M
Total Long-Term Assets $657.9M $622.8M
Total Assets $1.418B $1.191B
YoY Change 19.12% -5.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $49.07M $57.45M
YoY Change -14.58% -0.71%
Accrued Expenses $29.20M $38.80M
YoY Change -24.74% -20.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $167.0M $56.93M
YoY Change 193.32% 349.57%
Total Short-Term Liabilities $338.6M $240.1M
YoY Change 41.03% 26.91%
LONG-TERM LIABILITIES
Long-Term Debt $297.0M $314.0M
YoY Change -5.4% -5.14%
Other Long-Term Liabilities $104.2M $41.05M
YoY Change 153.81% 32.49%
Total Long-Term Liabilities $401.2M $355.0M
YoY Change 13.0% -1.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $338.6M $240.1M
Total Long-Term Liabilities $401.2M $355.0M
Total Liabilities $739.8M $595.1M
YoY Change 24.31% 7.98%
SHAREHOLDERS EQUITY
Retained Earnings $137.1M $85.63M
YoY Change 60.15% -55.94%
Common Stock $569.3M $534.2M
YoY Change 6.56% 0.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $667.9M $583.8M
YoY Change
Total Liabilities & Shareholders Equity $1.418B $1.191B
YoY Change 19.12% -5.94%

Cashflow Statement

Concept 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $48.10M $37.49M
YoY Change 28.32% 100.18%
Depreciation, Depletion And Amortization $20.90M $27.10M
YoY Change -22.88% 7.11%
Cash From Operating Activities $29.20M $29.90M
YoY Change -2.34% -47.91%
INVESTING ACTIVITIES
Capital Expenditures -$8.300M -$9.500M
YoY Change -12.63% -80.41%
Acquisitions
YoY Change
Other Investing Activities $45.50M $15.40M
YoY Change 195.45% 3750.0%
Cash From Investing Activities $37.10M $5.900M
YoY Change 528.81% -112.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -64.40M -112.5M
YoY Change -42.76% 112400.0%
NET CHANGE
Cash From Operating Activities 29.20M 29.90M
Cash From Investing Activities 37.10M 5.900M
Cash From Financing Activities -64.40M -112.5M
Net Change In Cash 1.900M -76.70M
YoY Change -102.48% -924.73%
FREE CASH FLOW
Cash From Operating Activities $29.20M $29.90M
Capital Expenditures -$8.300M -$9.500M
Free Cash Flow $37.50M $39.40M
YoY Change -4.82% -62.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000313143
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-03
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2699000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3824000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
299450000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
296942000 USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50703343 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50322930 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50322930 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50703343 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-26
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-14041
dei Entity Registrant Name
EntityRegistrantName
HAEMONETICS CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-2882273
dei Entity Address Address Line1
EntityAddressAddressLine1
125 Summer Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston,
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02110
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
848-7100
dei Security12b Title
Security12bTitle
Common stock, $.01 par value per share
dei Trading Symbol
TradingSymbol
HAE
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50777298 shares
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
209486000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
252566000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
405063000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
491017000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
103742000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
125566000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
209289000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
248111000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
105744000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
127000000 USD
us-gaap Gross Profit
GrossProfit
195774000 USD
us-gaap Gross Profit
GrossProfit
242906000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6763000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7422000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14513000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14909000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
71697000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
77922000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
141234000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
150922000 USD
CY2020Q3 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 USD
CY2019Q3 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
0 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
1028000 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
48721000 USD
CY2020Q3 hae Gain Loss On Divestiture And Sale Of Assets
GainLossOnDivestitureAndSaleOfAssets
31498000 USD
CY2019Q3 hae Gain Loss On Divestiture And Sale Of Assets
GainLossOnDivestitureAndSaleOfAssets
8083000 USD
hae Gain Loss On Divestiture And Sale Of Assets
GainLossOnDivestitureAndSaleOfAssets
31498000 USD
hae Gain Loss On Divestiture And Sale Of Assets
GainLossOnDivestitureAndSaleOfAssets
8083000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
46962000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
77261000 USD
us-gaap Operating Expenses
OperatingExpenses
125277000 USD
us-gaap Operating Expenses
OperatingExpenses
206469000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
58782000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
49739000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
70497000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
36437000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3826000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4651000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7561000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9074000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
54956000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
45088000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
62936000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
27363000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6855000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7602000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4308000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1644000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
48101000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
37486000 USD
us-gaap Net Income Loss
NetIncomeLoss
58628000 USD
us-gaap Net Income Loss
NetIncomeLoss
29007000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.94
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50696000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50791000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50557000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50901000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51093000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52046000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51170000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52174000 shares
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
53335000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
35378000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
65291000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23281000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
279169000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137311000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
141533000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
165207000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
305224000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
270276000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
34353000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
30845000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
760279000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
603639000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
240405000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
253399000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
127210000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
133106000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
214594000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
210652000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4306000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3930000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
71380000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
62384000 USD
CY2020Q3 us-gaap Assets
Assets
1418174000 USD
CY2020Q1 us-gaap Assets
Assets
1267110000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
167001000 USD
CY2020Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
76980000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
49071000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
50730000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
29226000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
49471000 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
93270000 USD
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
97641000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
338568000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
274822000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
297016000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1267110000 USD
CY2020Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
305513000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10480000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10562000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
104187000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
89104000 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
507000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
503000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
568748000 USD
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
553229000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
137140000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
78512000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-38472000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-45135000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
667923000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
587109000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1418174000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
587109000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2144000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1193000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6167000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
10527000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1429000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
608569000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
67000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5952000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
48101000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
48101000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5234000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
667923000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
667868000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1830000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3635000 USD
CY2019Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
75000000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4730000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-8479000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3618000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
590966000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2410000 USD
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
50000000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
37486000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2108000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
583754000 USD
us-gaap Net Income Loss
NetIncomeLoss
58628000 USD
us-gaap Net Income Loss
NetIncomeLoss
29007000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
41603000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
54469000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1028000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
48721000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
12119000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9730000 USD
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-3031000 USD
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-7290000 USD
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1057000 USD
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-1857000 USD
hae Gain Loss On Divestiture And Sale Of Assets
GainLossOnDivestitureAndSaleOfAssets
31498000 USD
hae Gain Loss On Divestiture And Sale Of Assets
GainLossOnDivestitureAndSaleOfAssets
8083000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
362000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
140000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-22391000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7806000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
38189000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
59439000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
635000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
1588000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1902000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
10616000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-24770000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-28471000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40967000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32529000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16035000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17722000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
16606000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
44978000 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
9808000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
902000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
15739000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13239000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7825000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
90000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
25000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8750000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4375000 USD
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
0 USD
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
125000000 USD
us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
2144000 USD
us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
1830000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1259000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6046000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-20000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
72000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
84633000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-96427000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3019000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1248000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
141858000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-57321000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137311000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
169351000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
279169000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112030000 USD
us-gaap Interest Paid Net
InterestPaidNet
4637000 USD
us-gaap Interest Paid Net
InterestPaidNet
6260000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4099000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8535000 USD
hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
4203000 USD
hae Transfers From Inventory To Fixed Assets
TransfersFromInventoryToFixedAssets
5780000 USD
CY2020Q1 us-gaap Restructuring Reserve
RestructuringReserve
2648000 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
992000 USD
CY2020Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
1960000 USD
CY2020Q3 us-gaap Restructuring Reserve
RestructuringReserve
1680000 USD
CY2020Q3 us-gaap Restructuring Charges
RestructuringCharges
-73000 USD
CY2019Q3 us-gaap Restructuring Charges
RestructuringCharges
1343000 USD
us-gaap Restructuring Charges
RestructuringCharges
992000 USD
us-gaap Restructuring Charges
RestructuringCharges
2312000 USD
CY2020Q3 us-gaap Restructuring Reserve
RestructuringReserve
1700000 USD
CY2020Q3 hae Restructuring Charges Payable In Next Twelve Months
RestructuringChargesPayableInNextTwelveMonths
1200000 USD
CY2020Q3 us-gaap Restructuring Charges
RestructuringCharges
-73000 USD
CY2019Q3 us-gaap Restructuring Charges
RestructuringCharges
1343000 USD
us-gaap Restructuring Charges
RestructuringCharges
992000 USD
us-gaap Restructuring Charges
RestructuringCharges
2312000 USD
CY2020Q3 hae Restructuring Related Costs
RestructuringRelatedCosts
4513000 USD
CY2019Q3 hae Restructuring Related Costs
RestructuringRelatedCosts
2414000 USD
hae Restructuring Related Costs
RestructuringRelatedCosts
7448000 USD
hae Restructuring Related Costs
RestructuringRelatedCosts
3472000 USD
CY2020Q3 hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
4440000 USD
CY2019Q3 hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
3757000 USD
hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
8440000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
37486000 USD
hae Restructuringand Restructuring Related Costs
RestructuringandRestructuringRelatedCosts
5784000 USD
CY2020Q3 us-gaap Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed
BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed
200000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6900000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4300000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.125
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.068
CY2020Q3 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
100000 USD
us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
4100000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1600000 USD
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.169
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.060
CY2019Q3 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
4400000 USD
us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
9300000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
48101000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
37486000 USD
us-gaap Net Income Loss
NetIncomeLoss
58628000 USD
us-gaap Net Income Loss
NetIncomeLoss
29007000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50696000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50791000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50557000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50901000 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
48101000 USD
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50791000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50557000 shares
us-gaap Net Income Loss
NetIncomeLoss
58628000 USD
us-gaap Net Income Loss
NetIncomeLoss
29007000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50696000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50901000 shares
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
397000 shares
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1255000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
613000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1273000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51093000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52046000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51170000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52174000 shares
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.94
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
800000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12421 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
19100000 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.61
CY2020Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2020Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
6700000 USD
CY2020Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
5000000.0 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
17500000 USD
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20800000 USD
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4800000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
13700000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2500000 USD
CY2020Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2500000 USD
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
82349000 USD
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
76867000 USD
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
13890000 USD
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
11021000 USD
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
208985000 USD
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
182388000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
305224000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
270276000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3446000 USD
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3624000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3824000 USD
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3937000 USD
CY2020Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
483000 USD
CY2019Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-586000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
742000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-286000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
264000 USD
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
102000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
383000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
115000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2699000 USD
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4108000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2699000 USD
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4108000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 segment
CY2020Q3 hae Net Revenues Before Foreign Exchange Impact
NetRevenuesBeforeForeignExchangeImpact
204455000 USD
CY2019Q3 hae Net Revenues Before Foreign Exchange Impact
NetRevenuesBeforeForeignExchangeImpact
249710000 USD
hae Net Revenues Before Foreign Exchange Impact
NetRevenuesBeforeForeignExchangeImpact
398055000 USD
hae Net Revenues Before Foreign Exchange Impact
NetRevenuesBeforeForeignExchangeImpact
485656000 USD
CY2020Q3 hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-311000 USD
CY2019Q3 hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-2420000 USD
hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-3416000 USD
hae Effectof Exchange Rateon Revenues
EffectofExchangeRateonRevenues
-4781000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
209486000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
252566000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
405063000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
491017000 USD
CY2020Q3 hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
3647000 USD
CY2019Q3 hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
2501000 USD
hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
4358000 USD
hae Effectof Exchange Rateson Operating Income
EffectofExchangeRatesonOperatingIncome
5270000 USD
CY2020Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
8136000 USD
CY2019Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
5935000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
16399000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
11909000 USD
CY2020Q3 hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
4440000 USD
CY2019Q3 hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
3757000 USD
hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
8440000 USD
hae Restructuringand Turnaround Costs
RestructuringandTurnaroundCosts
5784000 USD
CY2020Q3 hae Operating Expenses Transaction Costs
OperatingExpensesTransactionCosts
-1773000 USD
CY2019Q3 hae Operating Expenses Transaction Costs
OperatingExpensesTransactionCosts
0 USD
hae Operating Expenses Transaction Costs
OperatingExpensesTransactionCosts
-3063000 USD
hae Operating Expenses Transaction Costs
OperatingExpensesTransactionCosts
0 USD
CY2020Q3 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
644000 USD
CY2019Q3 us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
6534000 USD
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
2186000 USD
us-gaap Restructuring Reserve Accelerated Depreciation
RestructuringReserveAcceleratedDepreciation
12062000 USD
CY2020Q3 hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
736000 USD
CY2019Q3 hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
-180000 USD
hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
1489000 USD
hae European Medical Device Regulation Costs
EuropeanMedicalDeviceRegulationCosts
-147000 USD
CY2020Q3 hae Asset Impairment And Other Related Charges
AssetImpairmentAndOtherRelatedCharges
-68000 USD
CY2019Q3 hae Asset Impairment And Other Related Charges
AssetImpairmentAndOtherRelatedCharges
54000 USD
hae Asset Impairment And Other Related Charges
AssetImpairmentAndOtherRelatedCharges
896000 USD
hae Asset Impairment And Other Related Charges
AssetImpairmentAndOtherRelatedCharges
51220000 USD
CY2020Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
31498000 USD
CY2019Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
8083000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
31498000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
8083000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
58782000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
49739000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
70497000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
36437000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
209486000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
252566000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
405063000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
491017000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
209486000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
252566000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
405063000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
491017000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-45135000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
3757000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-2906000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6663000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-38472000 USD

Files In Submission

Name View Source Status
0000313143-20-000076-index-headers.html Edgar Link pending
0000313143-20-000076-index.html Edgar Link pending
0000313143-20-000076.txt Edgar Link pending
0000313143-20-000076-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hae-20200926.htm Edgar Link pending
hae-20200926.xsd Edgar Link pending
hae-20200926_cal.xml Edgar Link unprocessable
hae-20200926_def.xml Edgar Link unprocessable
hae-20200926_htm.xml Edgar Link completed
hae-20200926_lab.xml Edgar Link unprocessable
hae-20200926_pre.xml Edgar Link unprocessable
haeq2sep2021ex311.htm Edgar Link pending
haeq2sep2021ex312.htm Edgar Link pending
haeq2sep2021ex321.htm Edgar Link pending
haeq2sep2021ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending